Henan Taloph Pharmaceutical Stock Co. Ltd. Class ASSE: 600222

Announcement on Progress in Receiving the "Decision on No Further Review of the Anti-Monopoly Examination for Concentration of Undertakings" and Proposed Change of Controlling Shareholder and Actual Controller

· Issued by Henan Taloph Pharmaceutical Stock Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Progress in Receiving the "Decision on No Further Review of the Anti-Monopoly Examination for Concentration of Undertakings" and Proposed Change of Controlling Shareholder and Actual Controller

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis